Shopping Cart
- Remove All
- Your shopping cart is currently empty
Fanapanel (ZK200775) is a quinoxalinedione derivative and potent competitive antagonist of AMPAR for cerebrovascular-related studies.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $72 | In Stock |
Description | Fanapanel (ZK200775) is a quinoxalinedione derivative and potent competitive antagonist of AMPAR for cerebrovascular-related studies. |
Targets&IC50 | AMPA/kainate receptor:21 nM |
In vitro | In rat cortical slice experiments, the inhibitory effect of Fanapanel on AMPA receptors was measured to assess its activity. The Results showed that the IC50 value for Fanapanel's inhibition of AMPA-induced currents was 21 nM, demonstrating strong neuroprotective and anticonvulsant effects [1]. |
In vivo | In the permanent MCAO model, intravenous infusion of Fanapanel (0.1-10 mg/kg/h for 6 hours) reduced the infarct volume by 24-34%, and it remained effective even when administered 1-5 hours later (reducing infarct volume by 20-30%). In the transient MCAO model, immediate or delayed injection of Fanapanel (0.01-3 mg/kg/h) 2 hours after reperfusion reduced the infarct volume by approximately 45%. In the gerbil global cerebral ischemia model, Fanapanel protected the hippocampal CA1 region. Long-term toxicity studies (rats 6 mg/kg/h, dogs 0.2 mg/kg/h for 4 weeks) did not show renal or neurotoxicity [1]. |
Alias | ZK200775, ZK 200775, MPQX |
Molecular Weight | 409.25 |
Formula | C14H15F3N3O6P |
Cas No. | 161605-73-8 |
Smiles | O=C1NC=2C=C(C(=CC2N(C1=O)CP(=O)(O)O)N3CCOCC3)C(F)(F)F |
Relative Density. | 1.615g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMSO: 1 mg/mL (2.44 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.